Results 31 to 40 of about 35,344 (269)
Frontiers in ImmunologyIntroductionAnti-GQ1b antibody syndrome encompasses immune-mediated neuropathies targeting ganglioside GQ1b, classically presenting as Miller Fisher syndrome (MFS) with the triad of ophthalmoplegia, ataxia, and areflexia.
Juyuan Pan +4 more
doaj +1 more source
Acute Ophthalmoplegia; Same Disease, Different Variants: Anti GQ1b Antibody Syndrome
, 2018 Patients with Miller Fisher syndrome (MFS) are characterized by acute ophthalmoplegia (AO) and areflexia. MFS is an immune mediated process, triggered by an infection and includes incomplete forms, such as ophthalmoplegia, ataxia and a central nervous ...
Anna Carina Ergani +5 more
core +1 more source
Frontiers in Genetics, 2019 Myasthenia gravis (MG) is a rare, treatable antibody-mediated disease which is characterized by muscle weakness. The pathogenic antibodies are most frequently directed at the acetylcholine receptors (AChRs) at the skeletal muscle endplate.
Melissa Nel +3 more
doaj +1 more source
Clinical Case Reports, 2021 Hypopituitarism secondary to a pituitary metastasis is rare and difficult to diagnose since its symptoms are nonspecific. The presence of visual deficits and nerve palsies should suggest the presence of a pituitary metastasis in a cancer patient.
Ibtissem Oueslati +5 more
doaj +1 more source
Surgery for Pituitary Tumor Apoplexy Is Associated with Rapid Headache and Cranial Nerve Improvement
Current Oncology, 2022 Pituitary tumor apoplexy (PTA) classically comprises sudden-onset headache, loss of vision, ophthalmoparesis, and decreased consciousness. It typically results from hemorrhage and/or infarction within a pituitary adenoma.
Kevin A. Cross +13 more
doaj +1 more source
GCA Presenting as Complete Ophthalmoplegia
, 2023 Complete bilateral ophthalmoplegia is an uncommon manifestation of GCA. The proposed pathophysiology of ophthalmoplegia in GCA includes cranial nerve palsy and orbital ischemia.
Isha Ingle; Can Kocasarac; Gabrielle Bonhomme
core
Digital Cognitive Testing in Mitochondrial Disease: Validity and Challenges for Clinical Trial Use
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Primary mitochondrial disease is a group of genetic disorders caused by pathogenic variants in nuclear or mitochondrial DNA, often resulting in progressive neurodegeneration and cognitive decline. Current management is primarily supportive, though recent research offers hope for disease‐modifying treatments in the future.
Oksana Pogoryelova +9 more
wiley +1 more source
To wait for a spontaneous recovery of the third cranial nerve palsy occurring after the coiling of a PcomA aneurysm or to implement surgical treatment? A case report [PDF]
Vojnosanitetski Pregled, 2017 Introduction. In the last two decades a method of endovascular embolization has been imposed as a method of choice in the treatment of unruptured intracranial aneurysms.
Peulić Miodrag +3 more
doaj +1 more source
Copine‐4 Paraneoplastic Autoimmune Encephalitis
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT We characterize copine‐4 (CPNE4)‐IgG and report clinical associations. Among 844 samples with unclassified neural IgGs identified by mouse‐brain indirect immunofluorescence assay over 2 years, 5 samples (serum, 3; CSF, 2) from 3 patients produced a distinctive cerebrum‐restricted synaptic pattern.
Mimi S. Fang +12 more
wiley +1 more source
Frontiers in MedicineMiller-Fisher syndrome (MFS) is a rare variant of Guillain-Barre syndrome, classically characterized by a triad of symptoms, including ataxia, areflexia, and ophthalmoplegia.
Jin Huang +3 more
doaj +1 more source